Alzheimer's disease & dementia

A new drug could slow Alzheimer's: But can patients get it?

It's welcome news for Alzheimer's patients and their families: A Food and Drug Administration advisory panel unanimously recommended approval for Eli Lilly & Co.'s treatment donanemab. If given the agency's green light later ...

Diseases, Conditions, Syndromes

New insights into the role of salivary glands in Sjögren's disease

Sjögren's disease primarily affects the salivary and lacrimal glands, resulting in tissue inflammation characterized by the formation of tertiary lymphoid structures (TLS), and a loss of glandular function—resulting in ...

page 2 from 40